Peter's Memo: Alzheimer’s drug debacle
In June, the FDA approved the drug aducanumab (Aduhelm) to treat Alzheimer’s disease.
Continue reading this article with a NutritionAction subscription
Already a subscriber? Log in
In June, the FDA approved the drug aducanumab (Aduhelm) to treat Alzheimer’s disease.
Already a subscriber? Log in